Speaker Profile

M.D., Head of Medical Affairs, Mirvie

Dr. Cowan plays a critical role in guiding Mirvies continued clinical and commercial development of the Mirvie RNA platform, which is first to predict preeclampsia and preterm birth months before symptoms by revealing the underlying biology of each pregnancy.Dr. Cowan has dedicated her career as a boardcertified OBGYN to advancing womens and pregnancy health. Alison was the medical director for the diagnostics division at Hologic, where she collaborated with RD and the regulatory division to ensure safe and appropriate monitoring was in place for the diagnostics portfolio, helped to drive payer coverage for a novel diagnostic test with the market access team, and provided clinical insights and detailed analyses to the business development team. With over 12 years of clinical experience in both academic and community settings, she maintains a clinical practice as an OBGYN hospitalist.

Predicting Preeclampsia and Preterm Birth
Mirvie is developing the breakthrough Mirvie RNA platform to predict pregnancy complications months in advance, such as preeclampsia and preterm birth. We will present the companys landmark pregnancy health research, and show how the prediction of pregnancy complications can enable personalized care and the prevention of disease.

Clinical Dx Showcase:

Mirvie is shaping the future of pregnancy health by providing women, expecting parents and their doctors with an early detection window to intervene before unexpected pregnancy complications become a crisis.

 Session Abstract – PMWC 2024 Silicon Valley

Showcase Track S2 - January 24 9.00 A.M.-2.00 P.M.,Showcase Track S2 - January 25 9.00 A.M.-2.15 P.M.,Showcase Track S2 - January 26 9.00 A.M.-11.30 A.M.

The PMWC 2023 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.

  • Clinical Dx/Oncology (including Liquid Biopsy)
  • Clinical Dx/Cardio Vascular
  • Clinical Dx/Nerodegenerative


Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by SEP. 28TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required